We are live on
!
Find out more
FGP
Freestone Grove Partners Portfolio holdings
AUM
$15.6B
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter
Est. Return
+0.81%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.2B
AUM Growth
+$326M
(+2.4%)
Cap. Flow
+$206M
Cap. Flow
% of AUM
1.46%
Top 10 Holdings %
Top 10 Hldgs %
19%
Holding
1,229
New
515
Increased
214
Reduced
228
Closed
267
Avg Time Held Equity + Options
1.1
quarters
Top 10 Avg Time Held Equity + Options
0.6
quarters
Top 20 Avg Time Held Equity + Options
0.4
quarters
Avg Time Held Equity only
1.1
quarters
Top 10 Avg Time Held Equity only
0.6
quarters
Top 20 Avg Time Held Equity only
0.4
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$134M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$120M |
| 3 |
KKR & Co
KKR
|
+$113M |
| 4 |
Mondelez International
MDLZ
|
+$103M |
| 5 |
AXIS Capital
AXS
|
+$97.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$303M |
| 2 |
Boston Scientific
BSX
|
+$127M |
| 3 |
Lennar Class A
LEN
|
+$95.9M |
| 4 |
Martin Marietta Materials
MLM
|
+$94.6M |
| 5 |
Colgate-Palmolive
CL
|
+$92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.98% |
| 2 | Technology | 14.39% |
| 3 | Miscellaneous | 12.72% |
| 4 | Industrials | 12.27% |
| 5 | Healthcare | 11.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Pultegroup
PHM
$21.1B
| $21.4M | 0.15% |
+181,784
| New | +$23.3M |
2026 Q1
0 quarters
|
|
202
National Health Investors
NHI
$3.22B
| $20.9M | 0.15% |
258,023
-28,332
| -10% | -$2.36M |
2025 Q4
1 quarter
|
|
203
Cintas
CTAS
$81.6B
| $20.7M | 0.15% |
122,608
+85,814
| +233% | +$16.5M |
2025 Q2
3 quarters
|
|
204
Rexford Industrial Realty
REXR
$8.34B
| $20.7M | 0.15% |
+632,076
| New | +$23.7M |
2026 Q1
0 quarters
|
|
205
RadNet
RDNT
$5.63B
| $20.4M | 0.14% |
365,394
+184,383
| +102% | +$12.6M |
2025 Q3
2 quarters
|
|
206
HP
HPQ
$26.9B
| $20.4M | 0.14% |
+1,060,594
| New | +$20.6M |
2026 Q1
0 quarters
|
|
207
Essential Properties Realty Trust
EPRT
$5.58B
| $20.3M | 0.14% |
+669,637
| New | +$21.2M |
2026 Q1
0 quarters
|
|
208
Dianthus Therapeutics
DNTH
$4.55B
| $20.1M | 0.14% |
+239,943
| New | +$13.9M |
2026 Q1
0 quarters
|
|
209
VICI Properties
VICI
$25.3B
| $20M | 0.14% |
+731,781
| New | +$20.9M |
2026 Q1
0 quarters
|
|
210
Onto Innovation
ONTO
$13.5B
| $19.8M | 0.14% |
+96,509
| New | +$19.8M |
2026 Q1
0 quarters
|
|
211
Tenet Healthcare
THC
$21.7B
| $19.7M | 0.14% |
+104,187
| New | +$22M |
2026 Q1
0 quarters
|
|
212
ANI Pharmaceuticals
ANIP
$1.69B
| $19.6M | 0.14% |
254,230
+113,121
| +80% | +$8.83M |
2024 Q4
5 quarters
|
|
213
Tractor Supply
TSCO
$17.4B
| $19.5M | 0.14% |
+429,422
| New | +$21.9M |
2026 Q1
0 quarters
|
|
214
Ralliant Corp
RAL
$7.99B
| $19.2M | 0.14% |
462,361
+111,001
| +32% | +$5.22M |
2025 Q2
3 quarters
|
|
215
Okta
OKTA
$39.5B
| $19.2M | 0.14% |
244,206
-602,818
| -71% | -$50M |
2025 Q3
2 quarters
|
|
216
MSCI
MSCI
$41.3B
| $19.2M | 0.14% |
35,595
+32,691
| +1,126% | +$18.4M |
2025 Q2
3 quarters
|
|
217
Jack Henry & Associates
JKHY
$10.5B
| $19.2M | 0.14% |
+121,400
| New | +$20.8M |
2026 Q1
0 quarters
|
|
218
Lincoln Electric
LECO
$14.2B
| $18.6M | 0.13% |
74,808
+16,154
| +28% | +$4.32M |
2025 Q4
1 quarter
|
|
219
Oscar Health
OSCR
$10.6B
| $18.4M | 0.13% |
1,602,569
+1,093,633
| +215% | +$15.4M |
2025 Q4
1 quarter
|
|
220
Golar LNG
GLNG
$4.93B
| $18.3M | 0.13% |
338,908
+184,234
| +119% | +$8.13M |
2025 Q4
1 quarter
|
|
221
Lam Research
LRCX
$388B
| $18.1M | 0.13% |
84,644
-7,078
| -8% | -$1.58M |
2024 Q4
5 quarters
|
|
222
Apple
AAPL
$4.97T
| $18M | 0.13% |
+70,839
| New | +$18.4M |
2026 Q1
0 quarters
|
|
223
Boot Barn
BOOT
$3.64B
| $17.9M | 0.13% |
+122,331
| New | +$22.2M |
2026 Q1
0 quarters
|
|
224
DELISTED
KalVista Pharmaceuticals
KALV
| $17.8M | 0.13% |
882,906
+249,887
| +39% | +$4.03M |
2025 Q3
2 quarters
|
|
225
Braze
BRZE
$3.28B
| $17.8M | 0.13% |
752,747
+318,637
| +73% | +$6.89M |
2025 Q2
3 quarters
|
|
Similar funds
ECM
MIFH
GF
AIM
OTPPB
AA
IWC
Freestone Grove Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Freestone Grove Partners held 1,229 positions worth $14.2B, up 2.4% from $13.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Freestone Grove Partners's Q1 2026 filing shows 515 new, 214 increased, 228 reduced and 267 closed positions. Its largest new stake was Citigroup: 1,180,436 shares worth $134M. The largest sale was iShares Core S&P 500 ETF, an estimated $303M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Miscellaneous.
- Freestone Grove Partners's largest Q1 2026 buy was Citigroup: 1,180,436 shares worth $134M.
- Freestone Grove Partners added most to AXIS Capital in Q1 2026, an estimated $97.1M increase.
- Freestone Grove Partners's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $303M.
- Freestone Grove Partners fully exited Boston Scientific in Q1 2026, selling an estimated $127M.
- Freestone Grove Partners's ten largest holdings make up 19% of its $14.2B portfolio in Q1 2026.
- Freestone Grove Partners opened 515 new positions and closed 267 in Q1 2026.
- Freestone Grove Partners's portfolio value rose 2.4% quarter-over-quarter to $14.2B.
Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.